Biomarker study for liver disease after Fontan surgery
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks for blood and/or test markers that can better show how severe liver disease is in people who had the Fontan heart procedure. It also involves medical imaging and/or a liver biopsy or related procedures to help evaluate those markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older (men and women)
- Have had the Fontan procedure in the past
- Have been previously enrolled in a specific liver study called 91DK0214
- Have had a heart catheterization or a liver biopsy within the last 10 years
- Have approval from an NIH cardiology team and a pre-anesthesia team
- Be able to give written consent and follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the lungs and heart work together during exercise in people who have had the Fontan operation. The goal is to understand how lung function affects overall fitness, which can help improve care for Fontan patients.
This study tests a simple liver function test (called dual cholate clearance) to see how well it works in adults with a Fontan circulation or right heart failure. It aims to help doctors better detect liver problems in these heart conditions.
This study tests a simple method to monitor how well your organs are working after you've had Fontan surgery. It looks at easy physical tasks like standing up from a chair to see if they can help track your health and catch any problems early.
This study looks at whether placing a stent in the Fontan blood vessel can improve liver health and exercise ability in teenagers and young adults. If you are between 12 and 21 years old and need a stent in your Fontan pathway, you may be able to join.
This trial uses a special liver scan (FibroScan) to measure liver stiffness, which may help detect high pressure in the central veins returning blood to the heart. It is for people with heart failure who are already scheduled for a right heart catheterization.
This study looks at factors that affect heart health after a liver transplant. It may help doctors better predict and manage heart problems in people with end-stage liver disease who are getting a new liver.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.